Mats Jerkeman

28PUBLICATIONS
119CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Diagnostic radiographyCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 18, 2026
No association between temozolomide maintenance and survival after first-line treatment in primary CNS lymphoma.

|Jul 14, 2026
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial.

|Apr 22, 2026
Feasibility of patient-reported outcomes collection in clinical routine at a radiotherapy department.

|Oct 24, 2025
EHA-EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma.

Mats Jerkeman, Igor Aurer, Elias Campo

|Mar 27, 2025
Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden.

Mats Jerkeman, Karin Mellgren, Kristina Sonnevi

|Dec 18, 2024
Clinical characteristics and outcomes of 476 mantle cell lymphoma patients aged 80 years and older.

Simon Pahnke, Kossi D Abalo, Sara Ekberg

Pageof 5

Frequent Collaborators

4 joint publications

Ingrid Glimelius

3 joint publications

Kirsten Grønbæk

3 joint publications

Sara Ekberg

3 joint publications

Marek Trněný